What is AnaptysBio, Inc. Common Stock's Market Cap?

AnaptysBio, Inc. Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's Enterprise Value?

AnaptysBio, Inc. Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's Price / Sales?

AnaptysBio, Inc. Common Stock's Price / Sales is 7.0×, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's EV / Revenue?

AnaptysBio, Inc. Common Stock's EV / Revenue is 5.9×, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's EV / EBITDA?

AnaptysBio, Inc. Common Stock's EV / EBITDA is 33.2×, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's Revenue (TTM)?

AnaptysBio, Inc. Common Stock's Revenue (TTM) is $232.4M, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's Net Income (TTM)?

AnaptysBio, Inc. Common Stock's Net Income (TTM) is -$26.8M, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's EBITDA?

AnaptysBio, Inc. Common Stock's EBITDA is $41.3M, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's Diluted EPS (TTM)?

AnaptysBio, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.

What is AnaptysBio, Inc. Common Stock's EBITDA Margin?

AnaptysBio, Inc. Common Stock's EBITDA Margin is 17.8%, based on as-reported figures from SEC (XBRL) filings.

AnaptysBio, Inc. Common Stock (ANAB) Financial Statements

AnaptysBio, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0026ZDHT8

XNAS · usd

55.70▼ 0.90 (-1.59%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close56.60

Day's Range55.25 – 57.89

52-Week Range17.11 – 73.30

Volume294.7K

Avg Volume450.7K

Share Statistics

Shares Outstanding

Employees104

ExchangeXNAS

Listed2017-01-26

Share count as of May 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about AnaptysBio, Inc. Common Stock (ANAB)

What is AnaptysBio, Inc. Common Stock's Market Cap?: AnaptysBio, Inc. Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's Enterprise Value?: AnaptysBio, Inc. Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's Price / Sales?: AnaptysBio, Inc. Common Stock's Price / Sales is 7.0×, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's EV / Revenue?: AnaptysBio, Inc. Common Stock's EV / Revenue is 5.9×, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's EV / EBITDA?: AnaptysBio, Inc. Common Stock's EV / EBITDA is 33.2×, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's Revenue (TTM)?: AnaptysBio, Inc. Common Stock's Revenue (TTM) is $232.4M, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's Net Income (TTM)?: AnaptysBio, Inc. Common Stock's Net Income (TTM) is -$26.8M, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's EBITDA?: AnaptysBio, Inc. Common Stock's EBITDA is $41.3M, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's Diluted EPS (TTM)?: AnaptysBio, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.
What is AnaptysBio, Inc. Common Stock's EBITDA Margin?: AnaptysBio, Inc. Common Stock's EBITDA Margin is 17.8%, based on as-reported figures from SEC (XBRL) filings.